WHO ICTRP trial
A Study to Assess Efficacy and Safety of Fixed Dose Combination of Glimepiride…
CTRI/2020/11/029080 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2020/11/029080 |
|---|---|
| Public title | A Study to Assess Efficacy and Safety of Fixed Dose Combination of Glimepiride, Voglibose and Metformin Tablets in Comparison to Dual â?? Combination of Anti-Diabetic Drug in Patients with Type 2 Diabetes Mellitus. |
| Scientific title | A Multicenter, Randomized, Comparative Study to Assess Efficacy and Safety of Fixed Dose Combination of Glimepiride, Voglibose and Metformin Tablets in Comparison to Dual â?? Combination of Anti-Diabetic Drug in Patients with Type 2 Diabetes Mellitus |
| Primary sponsor | Sun Pharma Laboratories Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: E119- Type 2 diabetes mellitus without complications |
| Interventions | Intervention1: FDC of Glimepiride (1 mg/2 mg), Voglibose (0.2 mg), Metformin ER 500 mg tablets: One tablet twice daily orally for 24 weeks Control Intervention1: FDC of Voglibose (0.2 mg / 0.3 mg), Metformin (500 mg) tablets: One tablet… |
| Registration date | Dec 11, 2020 |
| Target size | 399 |
| Secondary IDs | ICR/19/005, Version No. 1.1, Dated 21/DEC/2020 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: